When Cronos Group (Nasdaq: CRON) started trading on Wall Street in 2018, it was a watershed moment. For the first time ever, investors were offered a pure marijuana play in the markets. In the years since, scores of other marijuana companies have joined the ranks of Cronos. Today, there are even marijuana ETFs available.
But since the early groundswell in marijuana investing, there’s been a lot of jockeying for position, but no clear front runner. In fact, since Tilray’s (Nasdaq: TLRY) wild ride shortly after its IPO, pot stocks as a whole have been pretty mellow. But values are on the rise…
Since the New Year, many of the larger marijuana stocks have been quietly ticking upwards. Once again there are whispers in Washington about the possibility of federal legalization. Whether the Biden administration chooses to move the goalpost in that direction has yet to be seen. But with or without a federal ruling, one thing is for certain. People are shelling out big bucks for bud across the country.
It’s estimated, medical marijuana sales broke $7 billion in 2020. Within just a few years, medical and recreational marijuana use is expected to be close to a $40 billion industry. Growth like that is hard to ignore. And it’s high time investors take notice.
The big question is what company (or companies) will breakout? Will there be a Coke vs. Pepsi type rivalry? Or will it appear more like the automotive industry with several companies becoming household names?
Betting on one stock is a gamble. Even those that litter their portfolio with pot stocks aren’t guaranteed a piece of the $40 billion action. This is where the benefit of marijuana ETFs come in. They do the diversification for you.
The Five Best Marijuana ETFs to invest in This Year
- AdvisorShares Pure US Cannabis ETF (NYSE: MSOS)
- ETFMG Alternative Harvest ETF (NYSE: MJ)
- Cambria Cannabis ETF (BATS: TOKE)
- AdvisorShares Pure Cannabis ETF (NYSE: YOLO)
- Cannabis ETF (NYSE: THCX)
AdvisorShares Pure US Cannabis ETF
At the top of our list is MSOS. One of the reasons it tops out our list of marijuana ETFs is that it is the only actively managed ETF dedicated solely to U.S. cannabis exposure. Because MSOS focuses exclusively on the largest marijuana market in the world – the U.S. – the potential here is extraordinary.
The other appeal here is that MSOS holdings are well diversified. Its holdings include growers, dispensaries, pharmaceutical companies and biotech firms focused on marijuana use. It also includes real estate companies focused on marijuana and developers of consumption devices and hydroponic growing systems.
If weed grows anywhere near as popular in the coming years as is expected, MSOS will be in a unique position to reward shareholders. Which is why this is one of our favorite marijuana ETFs to consider investing in.
ETFMG Alternative Harvest ETF
The MJ ETF is the largest one available that targets the global cannabis industry. And it gets bonus points for being the first ETF in the U.S. to target the industry.
Its top holdings are some of the biggest in the Canadian cannabis space. They include the likes of Tilray, Canopy Growth Corp (Nasdaq: CGC) and Aphria (Nasdaq: APHA) – which reached profitability faster than any of its Canadian peers.
But it’s the sheer diversity of holdings that makes MJ so appealing. The fund has exposure to agriculture products, biotech, growing products and paper product industries. And it has exposure in Canada, the U.S. United Kingdom, Swedish and Japanese markets. If cannabis markets tick upwards anywhere, MJ holders will see the benefit. And that makes this an excellent marijuana ETF to invest in and hold onto for a few years.
Cambria Cannabis ETF
This ETF is one of the new kids on the block. But what it lacks in age it makes up for in value. TOKE is one of the cheapest marijuana ETFs out there. That’s not enough to make it onto this list through.
The real reason TOKE is so appealing is because of Cambria’s founder and chief-investing-officer, Meb Faber. Faber is a classic value investor. And because TOKE is his firm’s only sector-focused fund, there’s good reason to believe the sector remains undervalued… At least for the time being. Faber’s thoughts on the cannabis industry are pretty transparent. Public perception of weed has shifted. And as sales move away from the black market, growth potential in the sector is still far from realized. And that makes this one of the most promising marijuana ETFs available.
AdvisorShares Pure Cannabis ETF
This ETF is designed to invest for pure cannabis exposure. It primarily invests in small- and mid-cap cannabis companies around the world. And at least 50% of revenue from any of the holdings in YOLO come from the marijuana and hemp industry.
The official breakdown in holdings by region focuses on North America… Which makes sense because that’s where the most movement in the market is. But this ETF’s outlook is favorable because of its diversity of sector exposure. As a long-term play, YOLO looks promising… Especially if legalization continues to spread.
Unlike the other ETFs on this list, THCX is a passively-managed fund. But it is also a pure-play in the cannabis sector.
THCX tracks the Innovative Labs Index – which is a rules-based portfolio that rebalances on a monthly basis. The whole reason behind the inception of THCX was to offer investors an easy way to gain exposure to stocks that are most likely to benefit from growth in the hemp and marijuana industries. And after looking at the fund’s holdings, it does so in spades.
As an added bonus, THCX has also started issuing dividend payments to investors. While the $0.87 per share distributed over the last four quarters might not sound like much, the possibility of future growth makes this marijuana ETF all the more appealing.
The Bottom Line on Marijuana ETFs
The cannabis industry struggled for years after it came out of the gate a little too hot. The nascent industry has already undergone the longest bear market in its history. But the rebound has begun. And 2021 is looking like it’s going to be a positive year for the marijuana industry.
Investors are already piling into the big names in the industry. And that’s pushing up share prices quickly. But these five marijuana ETFs are an even cheaper way in. And the way they’re set up all but ensures great earnings potential as sales increase.
However, Chief Trends Strategist Matthew Carr does suggest a bit of caution. As he recently wrote, “…we know the biggest cause for caution heading into 2021 is euphoria. The threat of overheated optimism inflating prices too quickly and the fear of missing out could lead to a bubble.”
To follow this story as it evolves and to get all the cannabis investment news you can use, we suggest signing up for our Profit Trends e-letter. By doing so, you’ll get Matthew Carr’s cannabis investment news delivered directly to your inbox while learning about all sorts of trends pushing the markets.